[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100609090":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":7,"locations":7,"responsibleParty":8,"collaborators":7,"id":12,"slug":13,"hasResults":14,"nctId":15,"briefTitle":16,"officialTitle":17,"acronym":7,"eligibilityCriteria":18,"healthyVolunteers":14,"sex":19,"minAge":20,"maxAge":7,"enrollmentInfo":21,"targetDuration":7,"studyType":24,"phases":7,"briefSummary":25,"conditions":26,"keywords":7,"overallStatus":28,"whyStopped":7,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":7},{"fullName":5,"class":6},"Assiut University","OTHER",null,{"type":9,"investigatorFullName":10,"investigatorTitle":11,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Amira Merzek","Resident at internal medicine department","100609090","what-is-the-prognostic-value-of-halp-score-monocytopenia-hypofibrinogenemia-and-astalt-ratio-in-patients-with-myelodysplastic-syndromes-100609090",false,"NCT07210034","What is the Prognostic Value of HALP Score, Monocytopenia, Hypofibrinogenemia, and AST\u002FALT Ratio in Patients With Myelodysplastic Syndromes","Prognostic Value of HALP Score, Monocytopenia, Hypofibrinogenemia, and AST\u002FALT Ratio in Patients With Myelodysplastic Syndromes at Assiut University Hospital.","Inclusion Criteria:\n\n* • Adults (≥18 years old) diagnosed with MDS according to WHO criteria\n\n  * Availability of complete medical records including laboratory data for hemoglobin, albumin, lymphocyte count, platelet count, monocyte count, fibrinogen level, AST and ALT\n  * Patients who were followed for at least 12 months post-diagnosis or until death\n\nExclusion Criteria:\n\n* Patients with active infections, liver cirrhosis, chronic inflammatory diseases, or concurrent malignancies at time of diagnosis\n* Incomplete laboratory or clinical data\n* Patients lost to follow-up within less than 3 months of diagnosis","ALL","18 Years",{"count":22,"type":23},100,"ESTIMATED","OBSERVATIONAL","to investigate prognostic significance of many factors in MDS including HALP score ( haemoglobin level, albumin level, lymphocyte, platelets), monocytopenia, hyperfibrinogenemia and AST\u002FALT ratio in patients with MDS at Assiut University Hospital.\n\nAnd to study overall survival and leukemia free survival rates in MDS patients.",[27],"Myelo Dysplastic Syndrome","NOT_YET_RECRUITING","2025-09-29",{"date":31,"type":32},"2025-10-07","ACTUAL",{"date":34,"type":23},"2026-01-01",{"date":36,"type":23},"2028-03-01",{"name":5,"class":6}]